Kaneka Corp., which began producing yeast-fermented CoQ10 in 1977, established its American home — Kaneka Nutrients — in Pasadena, Texas in 2006. By doing so, the Japanese group became the first company in the U.S. to manufacture ubiquinone, the oxidized form of CoQ10.
Following years of extensive research and development, Kaneka became pioneers in the field again in 2008 when it made the active, antioxidant form of CoQ10, known as ubiquinol, which is superior to its predecessor because it is the predominant form of CoQ10 produced by a healthy body.
Ubiquinol is a vitamin-like substance that contributes to the production of over 90 percent of the cellular energy utilized by the heart and other organs to operate at their optimum levels. The body’s ability to naturally produce ubiquinol diminishes with age and declining health.
Kaneka Ubiquinol™ can be found in hundreds of dietary supplements available to health-conscious consumers in many health food stores, grocers and pharmacies marketed under numerous well-known, high-quality brands.
Manufacturers of those supplements look for and trust Kaneka ingredients because they know that the company adheres to the strictest quality control at the Texas facility.
“As the American market for CoQ10 grew, we wanted to show our customers how committed we were to delivering CoQ10 and in particular ubiquinol, which was the next generation of CoQ10,” said Kaneka North America President Kazuhiko Fujii.
In clinical studies, ubiquinol has been shown to be more bioavailable than conventional CoQ10 and effectively replace depleted levels of CoQ10/ubiquinol associated with statin drug use. Also, because ubiquinol is the preferred form of CoQ10 in the body, studies have shown it is better for the heart and vascular health than conventional CoQ10.